首页 > 最新文献

Maternal-fetal medicine (Wolters Kluwer Health, Inc.)最新文献

英文 中文
Observations, Beliefs & Science Among Obstetricians on Kangaroo Mother Care in India. 印度产科医生对袋鼠妈妈护理的观察、信念和科学。
IF 1.7 Pub Date : 2026-07-01 Epub Date: 2025-09-26 DOI: 10.1097/FM9.0000000000000310
Aishwarya Karthik Nagesh, Shashikala Karanth, Aswathi Saji, Suman P N Rao

Objective: To obtain insights into the knowledge and attitudes of obstetricians towards "kangaroo mother care" (KMC), and to identify their role in it in India.

Methods: A cross-sectional observational study in the form of a comprehensive, structured questionnaire-based survey was conducted and disseminated to several obstetricians across various cities in India between January and June 2023 using an online survey tool by the "snowball" sampling method. Data were analyzed using descriptive statistics. Each response was assigned a specific weight. A scoring system was developed using the partial credit model. Scores were categorized using the Jenks break classification into "low", "moderate", and "high". The Mann-Whitney U test was carried out to explore the relationship between participant scores with age and location of practice.

Results: The final dataset consisted of 215 obstetricians across India. Most respondents (89.30%, 192/215) were aware of the impact of KMC on reducing neonatal mortality (though the precise figures were less known). The term "KMC" was used interchangeably with skin-to-skin contact at birth by 69.77% (150/215) of respondents. The "Belief section" received a positive response, with most participants advocating for antenatal counselling on KMC and its inclusion in obstetrics and gynecology, and pediatrics curricula. We found that 98 (45.6%) and 90 (41.9%) respondents scored moderate-to-high in the Science and Observations sections, respectively, and 90 (41.9%) excelled in the Beliefs section. There were significant associations (P = 0.011 and 0.018, respectively) between the age of the practitioner and his/her knowledge and practices of KMC, and between those who worked in academic centers compared with those who did not in terms of their beliefs towards KMC practices (P = 0.020), suggesting that exposure and experience in the field enhanced the understanding of KMC, highlighting the need for targeted training for new obstetricians.

Conclusion: Obstetricians exhibited positive attitudes and beliefs towards KMC and were ready to increase their knowledge and practices. It is crucial to collaborate and harness this potential to ensure their greater involvement in KMC implementation.

目的:了解印度产科医生对“袋鼠妈妈护理”(KMC)的认识和态度,并确定其在其中的作用。方法:采用“滚雪球”抽样法的在线调查工具,于2023年1月至6月对印度各城市的几位产科医生进行了全面的、结构化的问卷调查,并进行了横断面观察研究。数据分析采用描述性统计。每个回答都有一个特定的权重。采用部分学分模型开发了评分系统。分数用詹克斯分数法分为“低”、“中”和“高”。采用曼-惠特尼U检验来探讨参与者得分与年龄和练习地点之间的关系。结果:最终的数据集包括全印度215名产科医生。大多数应答者(89.30%,192/215)意识到KMC对降低新生儿死亡率的影响(尽管确切数字鲜为人知)。69.77%(150/215)的受访者将“KMC”一词与出生时皮肤接触交替使用。“信念部分”得到了积极的回应,大多数参与者都主张将KMC产前咨询纳入妇产科和儿科课程。我们发现,98名(45.6%)和90名(41.9%)受访者分别在科学和观察部分得分中高,90名(41.9%)受访者在信念部分表现优异。医生的年龄与其对KMC的认识和实践之间存在显著相关性(P分别为0.011和0.018),在学术中心工作的医生与未在学术中心工作的医生在对KMC实践的信念方面存在显著相关性(P = 0.020),表明在该领域的接触和经验增强了对KMC的理解,突出了对新产科医生进行有针对性培训的必要性。结论:产科医生对KMC表现出积极的态度和信念,并准备增加知识和实践。至关重要的是进行合作并利用这一潜力,以确保他们更多地参与KMC的实施。
{"title":"Observations, Beliefs & Science Among Obstetricians on Kangaroo Mother Care in India.","authors":"Aishwarya Karthik Nagesh, Shashikala Karanth, Aswathi Saji, Suman P N Rao","doi":"10.1097/FM9.0000000000000310","DOIUrl":"10.1097/FM9.0000000000000310","url":null,"abstract":"<p><strong>Objective: </strong>To obtain insights into the knowledge and attitudes of obstetricians towards \"kangaroo mother care\" (KMC), and to identify their role in it in India.</p><p><strong>Methods: </strong>A cross-sectional observational study in the form of a comprehensive, structured questionnaire-based survey was conducted and disseminated to several obstetricians across various cities in India between January and June 2023 using an online survey tool by the \"snowball\" sampling method. Data were analyzed using descriptive statistics. Each response was assigned a specific weight. A scoring system was developed using the partial credit model. Scores were categorized using the Jenks break classification into \"low\", \"moderate\", and \"high\". The Mann-Whitney <i>U</i> test was carried out to explore the relationship between participant scores with age and location of practice.</p><p><strong>Results: </strong>The final dataset consisted of 215 obstetricians across India. Most respondents (89.30%, 192/215) were aware of the impact of KMC on reducing neonatal mortality (though the precise figures were less known). The term \"KMC\" was used interchangeably with skin-to-skin contact at birth by 69.77% (150/215) of respondents. The \"Belief section\" received a positive response, with most participants advocating for antenatal counselling on KMC and its inclusion in obstetrics and gynecology, and pediatrics curricula. We found that 98 (45.6%) and 90 (41.9%) respondents scored moderate-to-high in the Science and Observations sections, respectively, and 90 (41.9%) excelled in the Beliefs section. There were significant associations (<i>P</i> = 0.011 and 0.018, respectively) between the age of the practitioner and his/her knowledge and practices of KMC, and between those who worked in academic centers compared with those who did not in terms of their beliefs towards KMC practices (<i>P</i> = 0.020), suggesting that exposure and experience in the field enhanced the understanding of KMC, highlighting the need for targeted training for new obstetricians.</p><p><strong>Conclusion: </strong>Obstetricians exhibited positive attitudes and beliefs towards KMC and were ready to increase their knowledge and practices. It is crucial to collaborate and harness this potential to ensure their greater involvement in KMC implementation.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 3","pages":"243-248"},"PeriodicalIF":1.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13387788/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148551674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Associated With Low Vaginal Birth Self-Efficacy Among High-Risk Pregnant Women. 高危孕妇阴道分娩自我效能低的相关因素。
IF 1.7 Pub Date : 2026-07-01 Epub Date: 2026-05-18 DOI: 10.1097/FM9.0000000000000360
Susanti, Ana Faizah, Silvia Mona, Hafizah Che Hassan, Suryanti Chan
{"title":"Factors Associated With Low Vaginal Birth Self-Efficacy Among High-Risk Pregnant Women.","authors":"Susanti, Ana Faizah, Silvia Mona, Hafizah Che Hassan, Suryanti Chan","doi":"10.1097/FM9.0000000000000360","DOIUrl":"10.1097/FM9.0000000000000360","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 3","pages":"318-320"},"PeriodicalIF":1.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13387756/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148681264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of Maternal Prepregnancy Obesity and Excessive Gestational Weight Gain on Fetal Growth: A Longitudinal Fetal Growth Study on a Chinese Cohort. 母亲孕前肥胖和妊娠期体重增加对胎儿生长的影响:一项中国队列胎儿生长的纵向研究。
IF 1.7 Pub Date : 2026-07-01 Epub Date: 2026-05-11 DOI: 10.1097/FM9.0000000000000350
Yujia Zhai, Yan Zhao, Xuening Li, Wen Gu, Wenqiang Li, Yunfei Qiu, Shuang Li, Mengxing Sun, Xiang Li, Wanning Qiu, Jun Ma, Yu Feng, Yijia Liang, Xiaoli Gong, Jiaxin Li, Yuan Wei, Tianchen Wu

Objective: To evaluate the independent effects of prepregnancy obesity and gestational weight gain on fetal growth patterns and explore whether prepregnancy obesity can modify the association between gestational weight gain and fetal growth trajectories.

Methods: A multicenter retrospective cohort was established, consisting of 9075 women with singleton pregnancies across 24 tertiary hospitals in 18 Chinese provinces. Each participant underwent a minimum of three ultrasound examinations between gestational week 12 and the conclusion of pregnancy. Fetal anthropometric measurements included biparietal diameter, abdominal circumference, head circumference, and femur length, with the estimated fetal weight (EFW) calculated using the Hadlock formula. Fetal growth trajectories were modeled using a linear mixed model with cubic splines, adjusted for maternal characteristics. Differences in trajectories were compared across categories of prepregnancy body mass index (BMI) and gestational weight gain. Global and week-specific comparisons were evaluated using the likelihood ratio test and the Wald test, while effect modification was assessed through stratified analysis.

Results: Fetal weight was positively associated with prepregnancy BMI and gestational weight gain. From gestational week 12 through week 40, the EFW significantly differed among the offspring of women categorized as underweight, normal weight, overweight, or obese. Specifically, fetuses of women with obesity presented a significantly higher EFW than those of women in the other groups. When stratified by gestational weight gain (inadequate, adequate, and excessive), significant differences in EFW were observed from gestational week 16 until the conclusion of the pregnancy. Stratified analysis indicated that prepregnancy BMI modified the association between gestational weight gain and fetal growth trajectories. In women without obesity, gestational weight gain was significantly and positively associated with EFW and abdominal circumference; however, in women with obesity, gestational weight gain did not demonstrate a significant effect on fetal growth trajectories.

Conclusion: Our data showed that prepregnancy BMI and gestational weight gain were positively associated with fetal growth. Furthermore, prepregnancy BMI acted as an effect modifier in the relationship between gestational weight gain and fetal growth trajectories. These findings suggested that weight control before conception carries greater clinical significance than the management of gestational weight gain.

目的:评价孕前肥胖和妊娠期体重增加对胎儿生长模式的独立影响,探讨孕前肥胖是否可以改变妊娠期体重增加与胎儿生长轨迹的关系。方法:采用多中心回顾性队列研究方法,纳入中国18个省24所三级医院的9075例单胎妊娠妇女。每位参与者在妊娠12周至妊娠结束期间至少接受三次超声检查。胎儿的人体测量包括双顶骨直径、腹围、头围和股骨长度,并使用Hadlock公式计算胎儿体重(EFW)。胎儿生长轨迹使用三次样条线性混合模型建模,并根据母体特征进行调整。比较了孕前体重指数(BMI)和妊娠期体重增加的不同类别的轨迹差异。采用似然比检验和Wald检验评估整体比较和周特异性比较,通过分层分析评估效应修正。结果:胎儿体重与孕前BMI和妊娠期体重增加呈正相关。从妊娠第12周到第40周,EFW在体重不足、正常体重、超重或肥胖妇女的后代中有显著差异。具体来说,肥胖女性的胎儿EFW明显高于其他组的胎儿。当按妊娠体重增加(不足、充足和过度)分层时,从妊娠第16周到妊娠结束,观察到EFW的显著差异。分层分析表明,孕前BMI改变了妊娠期体重增加与胎儿生长轨迹之间的关系。在没有肥胖的妇女中,妊娠期体重增加与EFW和腹围显著正相关;然而,在肥胖妇女中,妊娠期体重增加对胎儿生长轨迹没有显着影响。结论:我们的数据显示,孕前BMI和妊娠期体重增加与胎儿生长呈正相关。此外,孕前BMI在妊娠期体重增加和胎儿生长轨迹之间的关系中起到了调节作用。这些发现表明,孕前体重控制比控制妊娠期体重增加具有更大的临床意义。
{"title":"The Effects of Maternal Prepregnancy Obesity and Excessive Gestational Weight Gain on Fetal Growth: A Longitudinal Fetal Growth Study on a Chinese Cohort.","authors":"Yujia Zhai, Yan Zhao, Xuening Li, Wen Gu, Wenqiang Li, Yunfei Qiu, Shuang Li, Mengxing Sun, Xiang Li, Wanning Qiu, Jun Ma, Yu Feng, Yijia Liang, Xiaoli Gong, Jiaxin Li, Yuan Wei, Tianchen Wu","doi":"10.1097/FM9.0000000000000350","DOIUrl":"10.1097/FM9.0000000000000350","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the independent effects of prepregnancy obesity and gestational weight gain on fetal growth patterns and explore whether prepregnancy obesity can modify the association between gestational weight gain and fetal growth trajectories.</p><p><strong>Methods: </strong>A multicenter retrospective cohort was established, consisting of 9075 women with singleton pregnancies across 24 tertiary hospitals in 18 Chinese provinces. Each participant underwent a minimum of three ultrasound examinations between gestational week 12 and the conclusion of pregnancy. Fetal anthropometric measurements included biparietal diameter, abdominal circumference, head circumference, and femur length, with the estimated fetal weight (EFW) calculated using the Hadlock formula. Fetal growth trajectories were modeled using a linear mixed model with cubic splines, adjusted for maternal characteristics. Differences in trajectories were compared across categories of prepregnancy body mass index (BMI) and gestational weight gain. Global and week-specific comparisons were evaluated using the likelihood ratio test and the Wald test, while effect modification was assessed through stratified analysis.</p><p><strong>Results: </strong>Fetal weight was positively associated with prepregnancy BMI and gestational weight gain. From gestational week 12 through week 40, the EFW significantly differed among the offspring of women categorized as underweight, normal weight, overweight, or obese. Specifically, fetuses of women with obesity presented a significantly higher EFW than those of women in the other groups. When stratified by gestational weight gain (inadequate, adequate, and excessive), significant differences in EFW were observed from gestational week 16 until the conclusion of the pregnancy. Stratified analysis indicated that prepregnancy BMI modified the association between gestational weight gain and fetal growth trajectories. In women without obesity, gestational weight gain was significantly and positively associated with EFW and abdominal circumference; however, in women with obesity, gestational weight gain did not demonstrate a significant effect on fetal growth trajectories.</p><p><strong>Conclusion: </strong>Our data showed that prepregnancy BMI and gestational weight gain were positively associated with fetal growth. Furthermore, prepregnancy BMI acted as an effect modifier in the relationship between gestational weight gain and fetal growth trajectories. These findings suggested that weight control before conception carries greater clinical significance than the management of gestational weight gain.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 3","pages":"274-283"},"PeriodicalIF":1.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13387797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148551813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carbetocin in the Prevention of Postpartum Hemorrhage after Vaginal Birth: A Systematic Review and Meta-Analysis. 卡贝菌素预防阴道分娩后产后出血:一项系统综述和荟萃分析。
IF 1.7 Pub Date : 2026-07-01 Epub Date: 2026-02-04 DOI: 10.1097/FM9.0000000000000337
Nour A El-Goly, Ahmed M Maged, Ahmed Shamel, Wael El-Sherbiny
<p><strong>Objective: </strong>To evaluate the safety and efficacy of carbetocin for reducing blood loss following vaginal delivery (VD).</p><p><strong>Methods: </strong>Databases, including MEDLINE, Scopus, Web of Science, EMBASE, Cochrane Library, Scopus, and clinical trial registries, were screened from inception to November 2024 using keywords related to carbetocin, postpartum hemorrhage (PPH), postpartum blood loss, and VD. Only randomized controlled trials included participants who underwent VD, totaling 19 studies including 69,884 women. Seventeen studies were published in English, one in Spanish, and one in Chinese. The extracted data included study location, number of participants and characteristics, intervention (including dose, route, and timing of administration), primary and secondary outcome parameters, and trial registration details.</p><p><strong>Results: </strong>Thirteen studies with 64,731 participants compared carbetocin to oxytocin. Blood loss in the first 24 h was assessed in ten trials (7403 participants), which reported a mean difference (<i>MD</i>) of -28.13 mL (95% confidence interval (<i>CI</i>): -51.76, -4.50; <i>P</i> = 0.020). The difference between antepartum and postpartum hemoglobin levels was measured in seven trials (2737 participants), which reported an <i>MD</i> of -0.39 g/dl (95% <i>CI</i>: -0.48, -0.29; <i>P</i> < 0.001). PPH > 500 mL and severe PPH > 1000 mL were reported in ten and seven studies (64,416 and 63,789 participants, respectively), with odds ratios (<i>OR</i>s) of 0.99 (95% <i>CI</i>: 0.89, 1.10; <i>P</i> = 0.800) and 0.98 (95% <i>CI</i>: 0.89, 1.09; <i>P</i> = 0.720), respectively. The need for additional uterotonics was assessed in ten trials (34,852 participants), with an <i>OR</i> of 0.67 (95% <i>CI</i>: 0.49, 0.90; <i>P</i> = 0.008). Six studies (10,145 participants) compared carbetocin to syntometrine. Blood loss in the first 24 h was assessed in five trials (4853 participants), which reported an <i>MD</i> of -35.29 mL (95% <i>CI</i>: -75.68, 5.09; <i>P</i> = 0.090). The difference between the antepartum and postpartum hemoglobin levels was measured in four trials (860 participants), which reported an <i>MD</i> of -0.29 g/dl (95% <i>CI</i>: -0.48, -0.09; <i>P</i> = 0.004). PPH > 500 mL and severe PPH > 1000 mL were reported in five and four studies (4835 and 4733 participants, respectively), with <i>OR</i>s of 1.09 (95% <i>CI</i>: 0.96, 1.24; <i>P</i> = 0.170) and 0.93 (95% <i>CI</i>: 0.78, 1.09; <i>P</i> = 0.360), respectively. The need for additional uterotonics was calculated in five trials (4933 participants), with an <i>OR</i> of 0.93 (95% <i>CI</i>: 0.60, 1.46; <i>P</i> = 0.770).</p><p><strong>Conclusion: </strong>Carbetocin administration was associated with reduced blood loss during the first 24 h after VD, a less severe decrease in postpartum hemoglobin levels, and a reduced need for additional uterotonics compared with oxytocin administration.</p><p><strong>Registration: </stron
目的:评价卡贝菌素减少阴道分娩出血量的安全性和有效性。方法:对MEDLINE、Scopus、Web of Science、EMBASE、Cochrane Library、Scopus、临床试验注册库等数据库进行筛选,筛选时间从成立之日至2024年11月,使用与卡霉素、产后出血(PPH)、产后失血、VD相关的关键词。只有随机对照试验纳入了VD患者,共19项研究,包括69,884名女性。17项研究用英语发表,1项用西班牙语发表,1项用中文发表。提取的数据包括研究地点、受试者人数和特征、干预措施(包括剂量、途径和给药时间)、主要和次要结局参数以及试验注册细节。结果:13项涉及64,731名参与者的研究比较了催产素和催产素。在10项试验(7403名参与者)中评估了前24小时的失血量,报告的平均差异(MD)为-28.13 mL(95%置信区间(CI): -51.76, -4.50;P = 0.020)。7项试验(2737名参与者)测量了产前和产后血红蛋白水平的差异,报告的MD为-0.39 g/dl (95% CI: -0.48, -0.29; P < 0.001)。10项和7项研究(分别为64,416和63,789名参与者)报告了PPH > 500 mL和重度PPH > 1000 mL,优势比(or)分别为0.99 (95% CI: 0.89, 1.10; P = 0.800)和0.98 (95% CI: 0.89, 1.09; P = 0.720)。在10项试验(34,852名参与者)中评估了额外子宫强张的必要性,OR为0.67 (95% CI: 0.49, 0.90; P = 0.008)。6项研究(10145名参与者)比较了卡贝菌素和赛托咪嗪。5项试验(4853名参与者)评估了前24小时的失血量,报告MD为-35.29 mL (95% CI: -75.68, 5.09; P = 0.090)。四项试验(860名参与者)测量了产前和产后血红蛋白水平的差异,结果显示MD为-0.29 g/dl (95% CI: -0.48, -0.09; P = 0.004)。PPH > 500 mL和重度PPH > 1000 mL分别在5项和4项研究(分别为4835和4733名参与者)中报道,or分别为1.09 (95% CI: 0.96, 1.24; P = 0.170)和0.93 (95% CI: 0.78, 1.09; P = 0.360)。在5项试验(4933名受试者)中计算了额外子宫强张的需求,OR为0.93 (95% CI: 0.60, 1.46; P = 0.770)。结论:与催产素相比,卡贝菌素可减少VD后24小时内的出血量,降低产后血红蛋白水平,减少额外的子宫强张需求。报名:注册号CRD42023492407。
{"title":"Carbetocin in the Prevention of Postpartum Hemorrhage after Vaginal Birth: A Systematic Review and Meta-Analysis.","authors":"Nour A El-Goly, Ahmed M Maged, Ahmed Shamel, Wael El-Sherbiny","doi":"10.1097/FM9.0000000000000337","DOIUrl":"10.1097/FM9.0000000000000337","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To evaluate the safety and efficacy of carbetocin for reducing blood loss following vaginal delivery (VD).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Databases, including MEDLINE, Scopus, Web of Science, EMBASE, Cochrane Library, Scopus, and clinical trial registries, were screened from inception to November 2024 using keywords related to carbetocin, postpartum hemorrhage (PPH), postpartum blood loss, and VD. Only randomized controlled trials included participants who underwent VD, totaling 19 studies including 69,884 women. Seventeen studies were published in English, one in Spanish, and one in Chinese. The extracted data included study location, number of participants and characteristics, intervention (including dose, route, and timing of administration), primary and secondary outcome parameters, and trial registration details.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Thirteen studies with 64,731 participants compared carbetocin to oxytocin. Blood loss in the first 24 h was assessed in ten trials (7403 participants), which reported a mean difference (&lt;i&gt;MD&lt;/i&gt;) of -28.13 mL (95% confidence interval (&lt;i&gt;CI&lt;/i&gt;): -51.76, -4.50; &lt;i&gt;P&lt;/i&gt; = 0.020). The difference between antepartum and postpartum hemoglobin levels was measured in seven trials (2737 participants), which reported an &lt;i&gt;MD&lt;/i&gt; of -0.39 g/dl (95% &lt;i&gt;CI&lt;/i&gt;: -0.48, -0.29; &lt;i&gt;P&lt;/i&gt; &lt; 0.001). PPH &gt; 500 mL and severe PPH &gt; 1000 mL were reported in ten and seven studies (64,416 and 63,789 participants, respectively), with odds ratios (&lt;i&gt;OR&lt;/i&gt;s) of 0.99 (95% &lt;i&gt;CI&lt;/i&gt;: 0.89, 1.10; &lt;i&gt;P&lt;/i&gt; = 0.800) and 0.98 (95% &lt;i&gt;CI&lt;/i&gt;: 0.89, 1.09; &lt;i&gt;P&lt;/i&gt; = 0.720), respectively. The need for additional uterotonics was assessed in ten trials (34,852 participants), with an &lt;i&gt;OR&lt;/i&gt; of 0.67 (95% &lt;i&gt;CI&lt;/i&gt;: 0.49, 0.90; &lt;i&gt;P&lt;/i&gt; = 0.008). Six studies (10,145 participants) compared carbetocin to syntometrine. Blood loss in the first 24 h was assessed in five trials (4853 participants), which reported an &lt;i&gt;MD&lt;/i&gt; of -35.29 mL (95% &lt;i&gt;CI&lt;/i&gt;: -75.68, 5.09; &lt;i&gt;P&lt;/i&gt; = 0.090). The difference between the antepartum and postpartum hemoglobin levels was measured in four trials (860 participants), which reported an &lt;i&gt;MD&lt;/i&gt; of -0.29 g/dl (95% &lt;i&gt;CI&lt;/i&gt;: -0.48, -0.09; &lt;i&gt;P&lt;/i&gt; = 0.004). PPH &gt; 500 mL and severe PPH &gt; 1000 mL were reported in five and four studies (4835 and 4733 participants, respectively), with &lt;i&gt;OR&lt;/i&gt;s of 1.09 (95% &lt;i&gt;CI&lt;/i&gt;: 0.96, 1.24; &lt;i&gt;P&lt;/i&gt; = 0.170) and 0.93 (95% &lt;i&gt;CI&lt;/i&gt;: 0.78, 1.09; &lt;i&gt;P&lt;/i&gt; = 0.360), respectively. The need for additional uterotonics was calculated in five trials (4933 participants), with an &lt;i&gt;OR&lt;/i&gt; of 0.93 (95% &lt;i&gt;CI&lt;/i&gt;: 0.60, 1.46; &lt;i&gt;P&lt;/i&gt; = 0.770).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Carbetocin administration was associated with reduced blood loss during the first 24 h after VD, a less severe decrease in postpartum hemoglobin levels, and a reduced need for additional uterotonics compared with oxytocin administration.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Registration: &lt;/stron","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 3","pages":"284-294"},"PeriodicalIF":1.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13387787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148551491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics of Early-Onset Severe Hemolytic Disease of the Fetus and Newborn and Treatment Efficacy of Serial Intrauterine Transfusions: A 10-Year Single-Center Experience in China. 早发性胎儿和新生儿严重溶血性疾病的临床特点及连续宫内输血治疗效果:中国10年单中心经验
IF 1.7 Pub Date : 2026-07-01 Epub Date: 2026-04-08 DOI: 10.1097/FM9.0000000000000346
Quanrui Liu, Jingya Zhao, Jingyu Liu, Danlun Li, Zhiming He, Yanmin Luo, Yi Zhou

Objective: To summarize the clinical characteristics of early-onset severe hemolytic disease of the fetus and newborn (HDFN) in a Chinese cohort and identify factors influencing intrauterine transfusion (IUT) frequency and pregnancy outcomes.

Methods: This retrospective cohort study included cases managed between 2013 and 2022. Factors affecting IUT efficacy were analyzed with regard to subsequent IUT risk and adverse pregnancy outcomes. Survival analysis for recurrent events was performed to assess subsequent IUT risk.

Results: Of the 97 cases included, 38 were identified as early-onset severe HDFN. Compared with non-early-onset severe HDFN, early-onset severe HDFN was characterized by higher anti-D titer (1:1024 vs. 1:512, respectively, P = 0.006), multiple alloantibodies (50.00% vs. 20.34%, respectively, P = 0.002), and an earlier gestational age at initial IUT (22.4 ± 3.2 vs. 29.0 ± 3.5 weeks, respectively, P < 0.001). In addition, early-onset severe HDFN correlated with increased IUT frequency (hazard ratio (HR): 2.01, 95% confidence interval (CI): 1.26-3.20, P = 0.003). Factors prolonging IUT intervals included transfused volume (HR: 0.99, 95% CI: 0.97-0.99; P < 0.001), hematocrit after IUT (HR: 0.96, 95% CI: 0.95-0.98; P < 0.001), and immunotherapy (HR: 0.59, 95% CI: 0.38-0.93; P = 0.024).

Conclusion: The characteristics of early-onset severe HDFN in Chinese patients are different from those observed in western cohorts. These patients frequently present with higher anti-D titers and a more complex spectrum of multiple alloantibodies. The occurrence of early-onset severe HDFN is associated with an increased frequency of IUT and lower live birth rates. Therefore, exploring effective interventions to delay the first IUT is critical to optimizing the timing and efficacy of intrauterine management for these high-risk cases.

目的:总结中国早发型严重胎儿和新生儿溶血病(hddn)的临床特点,探讨影响宫内输注(IUT)频率和妊娠结局的因素。方法:本回顾性队列研究纳入2013年至2022年管理的病例。分析影响宫内节育器疗效的因素,包括随后的宫内节育器风险和不良妊娠结局。对复发事件进行生存分析以评估随后的IUT风险。结果:在纳入的97例病例中,38例被确定为早发性严重hdf。与非早发性重度HDFN患者相比,早发性重度HDFN患者具有更高的抗d滴度(分别为1:1024比1:12 12,P = 0.006)、多种同种异体抗体(分别为50.00%比20.34%,P = 0.002)、早期IUT胎龄(分别为22.4±3.2比29.0±3.5周,P < 0.001)。此外,早发型严重HDFN与IUT频率增加相关(风险比(HR): 2.01, 95%可信区间(CI): 1.26-3.20, P = 0.003)。延长IUT间隔时间的因素包括输液量(HR: 0.99, 95% CI: 0.97-0.99; P < 0.001)、IUT后红细胞压积(HR: 0.96, 95% CI: 0.95-0.98; P < 0.001)和免疫治疗(HR: 0.59, 95% CI: 0.38-0.93; P = 0.024)。结论:中国早发重症hdf患者的特点与西方患者不同。这些患者通常具有较高的抗d滴度和更复杂的多种同种异体抗体谱。早发性严重HDFN的发生与IUT频率增加和活产率降低有关。因此,探索有效的干预措施延迟首次IUT对于优化这些高危病例的宫内管理时机和效果至关重要。
{"title":"Clinical Characteristics of Early-Onset Severe Hemolytic Disease of the Fetus and Newborn and Treatment Efficacy of Serial Intrauterine Transfusions: A 10-Year Single-Center Experience in China.","authors":"Quanrui Liu, Jingya Zhao, Jingyu Liu, Danlun Li, Zhiming He, Yanmin Luo, Yi Zhou","doi":"10.1097/FM9.0000000000000346","DOIUrl":"10.1097/FM9.0000000000000346","url":null,"abstract":"<p><strong>Objective: </strong>To summarize the clinical characteristics of early-onset severe hemolytic disease of the fetus and newborn (HDFN) in a Chinese cohort and identify factors influencing intrauterine transfusion (IUT) frequency and pregnancy outcomes.</p><p><strong>Methods: </strong>This retrospective cohort study included cases managed between 2013 and 2022. Factors affecting IUT efficacy were analyzed with regard to subsequent IUT risk and adverse pregnancy outcomes. Survival analysis for recurrent events was performed to assess subsequent IUT risk.</p><p><strong>Results: </strong>Of the 97 cases included, 38 were identified as early-onset severe HDFN. Compared with non-early-onset severe HDFN, early-onset severe HDFN was characterized by higher anti-D titer (1:1024 <i>vs</i>. 1:512, respectively, <i>P</i> = 0.006), multiple alloantibodies (50.00% <i>vs</i>. 20.34%, respectively, <i>P</i> = 0.002), and an earlier gestational age at initial IUT (22.4 ± 3.2 <i>vs</i>. 29.0 ± 3.5 weeks, respectively, <i>P</i> < 0.001). In addition, early-onset severe HDFN correlated with increased IUT frequency (hazard ratio (<i>HR</i>): 2.01, 95% confidence interval (<i>CI</i>): 1.26-3.20, <i>P</i> = 0.003). Factors prolonging IUT intervals included transfused volume (<i>HR</i>: 0.99, 95% <i>CI</i>: 0.97-0.99; <i>P</i> < 0.001), hematocrit after IUT (<i>HR</i>: 0.96, 95% <i>CI</i>: 0.95-0.98; <i>P</i> < 0.001), and immunotherapy (<i>HR</i>: 0.59, 95% <i>CI</i>: 0.38-0.93; <i>P</i> = 0.024).</p><p><strong>Conclusion: </strong>The characteristics of early-onset severe HDFN in Chinese patients are different from those observed in western cohorts. These patients frequently present with higher anti-D titers and a more complex spectrum of multiple alloantibodies. The occurrence of early-onset severe HDFN is associated with an increased frequency of IUT and lower live birth rates. Therefore, exploring effective interventions to delay the first IUT is critical to optimizing the timing and efficacy of intrauterine management for these high-risk cases.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 3","pages":"265-273"},"PeriodicalIF":1.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13387801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148551616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional Study of Al Kaissi Syndrome Caused by a Prenatal CDK10 Compound Heterozygous Mutation. 产前CDK10复合杂合突变致Al Kaissi综合征的功能研究。
IF 1.7 Pub Date : 2026-07-01 Epub Date: 2026-02-13 DOI: 10.1097/FM9.0000000000000339
Qiao He, Xiaoping Yin, Zhu Ye, Danqing Zhao
{"title":"Functional Study of Al Kaissi Syndrome Caused by a Prenatal <i>CDK10</i> Compound Heterozygous Mutation.","authors":"Qiao He, Xiaoping Yin, Zhu Ye, Danqing Zhao","doi":"10.1097/FM9.0000000000000339","DOIUrl":"10.1097/FM9.0000000000000339","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 3","pages":"309-311"},"PeriodicalIF":1.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13387754/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148551647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-Mortem Genetic Testing in Fetal Loss: Challenges and Strategies to Maximizing Diagnostic Value From Devitalized Tissues. 胎儿丢失的死后基因检测:从失活组织中最大化诊断价值的挑战和策略。
IF 1.7 Pub Date : 2026-07-01 Epub Date: 2026-05-08 DOI: 10.1097/FM9.0000000000000354
Mishu Mangla, Seetu Palo, Rohini Motwani
{"title":"Post-Mortem Genetic Testing in Fetal Loss: Challenges and Strategies to Maximizing Diagnostic Value From Devitalized Tissues.","authors":"Mishu Mangla, Seetu Palo, Rohini Motwani","doi":"10.1097/FM9.0000000000000354","DOIUrl":"10.1097/FM9.0000000000000354","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 3","pages":"312-314"},"PeriodicalIF":1.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13387794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148551717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Decade of Evolution in Ultrasound in Obstetrics and Gynecology Literature (2015-2025): A Bibliometric and Visualization Analysis From a Leading Specialty Journal Perspective. 超声在妇产科文献中的十年演变(2015-2025):从领先专业期刊的角度进行文献计量和可视化分析。
IF 1.7 Pub Date : 2026-07-01 Epub Date: 2026-05-22 DOI: 10.1097/FM9.0000000000000358
Hairui Wang, Xueqin Ji, Xia Ren, Yingying Cai, Yanfeihai Li, Yaping Yu, Cailing Ye, Simin Zhang
{"title":"A Decade of Evolution in Ultrasound in Obstetrics and Gynecology Literature (2015-2025): A Bibliometric and Visualization Analysis From a Leading Specialty Journal Perspective.","authors":"Hairui Wang, Xueqin Ji, Xia Ren, Yingying Cai, Yanfeihai Li, Yaping Yu, Cailing Ye, Simin Zhang","doi":"10.1097/FM9.0000000000000358","DOIUrl":"10.1097/FM9.0000000000000358","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 3","pages":"321-324"},"PeriodicalIF":1.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13387784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148551552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standards and Norms: Expert Consensus on Exercise for Pregnant and Postpartum Women (2026 Revision). 标准规范:《孕妇产后锻炼专家共识(2026年修订版)》。
IF 1.7 Pub Date : 2026-07-01 Epub Date: 2026-05-26 DOI: 10.1097/FM9.0000000000000359

Exercise during pregnancy and the postpartum period is important for maternal and infant health. To standardize clinical practice regarding exercise for pregnant and postpartum women in China, the Chinese Society of Perinatal Medicine of the Chinese Medical Association and the China Institute of Sport Science, General Administration of Sport of China, jointly developed this expert consensus. This consensus was informed by the latest evidence from clinical research, relevant guidelines, and expert opinion. It was developed using the Delphi method through three rounds of expert consultation, together with multidisciplinary discussions, resulting in the expert consensus. This consensus addresses key topics, including eligible populations for exercise during pregnancy, exercise contraindications, exercise prescription components, and postpartum exercise, and provides 10 key recommendations. It aims to offer scientific, practical, and actionable guidance for exercise interventions among pregnant and postpartum women in China and to promote the integration of sports and medicine in perinatal health management.

孕期及产后运动对母婴健康十分重要。为规范我国孕妇产后运动的临床实践,中华医学会围产期医学分会与国家体育总局中国体育科学研究所共同制定了本专家共识。来自临床研究的最新证据、相关指南和专家意见为这一共识提供了依据。采用德尔菲法,经过三轮专家咨询,结合多学科讨论,形成专家共识。这一共识解决了关键问题,包括怀孕期间运动的合格人群、运动禁忌症、运动处方成分和产后运动,并提供了10项关键建议。旨在为中国孕妇和产后妇女的运动干预提供科学、实用、可操作的指导,促进围产期健康管理中运动与医学的结合。
{"title":"Standards and Norms: Expert Consensus on Exercise for Pregnant and Postpartum Women (2026 Revision).","authors":"","doi":"10.1097/FM9.0000000000000359","DOIUrl":"10.1097/FM9.0000000000000359","url":null,"abstract":"<p><p>Exercise during pregnancy and the postpartum period is important for maternal and infant health. To standardize clinical practice regarding exercise for pregnant and postpartum women in China, the Chinese Society of Perinatal Medicine of the Chinese Medical Association and the China Institute of Sport Science, General Administration of Sport of China, jointly developed this expert consensus. This consensus was informed by the latest evidence from clinical research, relevant guidelines, and expert opinion. It was developed using the Delphi method through three rounds of expert consultation, together with multidisciplinary discussions, resulting in the expert consensus. This consensus addresses key topics, including eligible populations for exercise during pregnancy, exercise contraindications, exercise prescription components, and postpartum exercise, and provides 10 key recommendations. It aims to offer scientific, practical, and actionable guidance for exercise interventions among pregnant and postpartum women in China and to promote the integration of sports and medicine in perinatal health management.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 3","pages":"217-226"},"PeriodicalIF":1.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13387768/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148551822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global, Regional, and National Burden of Infertility Attributable to Sexually Transmitted Infections From 1990 to 2021, With Projections to 2050. 1990年至2021年全球、地区和国家性传播感染导致的不孕症负担,并预测到2050年。
IF 1.7 Pub Date : 2026-07-01 Epub Date: 2026-03-10 DOI: 10.1097/FM9.0000000000000324
Ning Zhang, Run Miao, Haoyu He, Yuzhou Gao, Zhikang Zhang, Dongmei Ji

Objective: To explore the specific impact of sexually transmitted infections (STIs) on infertility including differences in disease burden among different regions and populations and temporal trends.

Methods: Data on STI-attributable infertility were extracted from the Global Burden of Diseases Study 2021. The study focused on two types of infertility (primary and secondary) and three STIs (chlamydia, gonococcal, and other STIs). The disease burden was measured using the age-standardized prevalence rate (ASPR) and the age-standardized years lived with disability (YLD) rate (ASYR). The estimated annual percent change (EAPC) was calculated to determine temporal variations. Temporal trends were modeled using joinpoint analysis and the age-period-cohort-Web tool. Finally, future trends were predicted using the Bayesian age-period-cohort model.

Results: In 2021, there were 18,413,845 (95% uncertainty interval (UI): 15,765,620-21,547,032) prevalent cases and 102,961 (95% UI: 40,469-213,098) YLDs associated with STI-attributable infertility globally. The corresponding ASPR and ASYR per 100,000 population were 225.44 (95% UI: 193.19-262.80) and 1.26 (95% UI: 0.50-2.61), with EAPCs from 1990 to 2021 of 0 (95% confidence interval (CI): -0.05-0.06) and -0.01 (95% CI: -0.07-0.04), respectively. Chlamydia infection was identified as the primary contributor to this burden. Nationally, Guinea-Bissau had the highest burden, followed by Guinea and Mauritania. A significant inverse correlation was observed between the ASPR and socio-demographic index (SDI) levels. From 1990 to 2021, the disease burden exhibited an upward trend. Notably, the model predicted this increasing trend would continue across all age groups until 2050, with individuals aged 40 to 44 being the most affected.

Conclusion: Infertility attributable to STIs remains a critical public health challenge, with a projected increasing trend through 2050. Global efforts to reduce the burden of infertility should focus on improving STI prevention, diagnosis, and treatment strategies, especially in regions with low and middle SDI levels.

目的:探讨性传播感染(STIs)对不孕不育的具体影响,包括不同地区和人群的疾病负担差异及时间趋势。方法:从2021年全球疾病负担研究中提取性传播感染导致的不孕症数据。该研究的重点是两种类型的不孕症(原发性和继发性)和三种性传播感染(衣原体、淋球菌和其他性传播感染)。疾病负担采用年龄标准化患病率(ASPR)和年龄标准化残疾生活年数(YLD)率(ASYR)来衡量。计算估算的年变化百分比(EAPC)以确定时间变化。使用连接点分析和年龄-时期-队列-网络工具对时间趋势进行建模。最后,使用贝叶斯年龄-时期-队列模型预测未来趋势。结果:2021年,全球共有18,413,845例(95%不确定区间(UI): 15,765,620-21,547,032)与性传播感染引起的不孕相关的流行病例和102,961例(95% UI: 40,469-213,098) yld。相应的每10万人口的ASPR和ASYR分别为225.44 (95% UI: 193.19 ~ 262.80)和1.26 (95% UI: 0.50 ~ 2.61), 1990 ~ 2021年的EAPCs分别为0(95%置信区间(CI): -0.05 ~ 0.06)和-0.01 (95% CI: -0.07 ~ 0.04)。衣原体感染被确定为造成这一负担的主要因素。从全国来看,几内亚比绍的负担最重,其次是几内亚和毛里塔尼亚。ASPR与社会人口指数(SDI)水平呈显著负相关。从1990年到2021年,疾病负担呈上升趋势。值得注意的是,该模型预测,这种增长趋势将在所有年龄组中持续到2050年,其中40至44岁的人受影响最大。结论:性传播感染导致的不孕症仍然是一个重大的公共卫生挑战,预计到2050年将呈上升趋势。减少不孕症负担的全球努力应侧重于改善性传播感染的预防、诊断和治疗策略,特别是在低和中等性传播感染水平的地区。
{"title":"Global, Regional, and National Burden of Infertility Attributable to Sexually Transmitted Infections From 1990 to 2021, With Projections to 2050.","authors":"Ning Zhang, Run Miao, Haoyu He, Yuzhou Gao, Zhikang Zhang, Dongmei Ji","doi":"10.1097/FM9.0000000000000324","DOIUrl":"10.1097/FM9.0000000000000324","url":null,"abstract":"<p><strong>Objective: </strong>To explore the specific impact of sexually transmitted infections (STIs) on infertility including differences in disease burden among different regions and populations and temporal trends.</p><p><strong>Methods: </strong>Data on STI-attributable infertility were extracted from the Global Burden of Diseases Study 2021. The study focused on two types of infertility (primary and secondary) and three STIs (chlamydia, gonococcal, and other STIs). The disease burden was measured using the age-standardized prevalence rate (ASPR) and the age-standardized years lived with disability (YLD) rate (ASYR). The estimated annual percent change (EAPC) was calculated to determine temporal variations. Temporal trends were modeled using joinpoint analysis and the age-period-cohort-Web tool. Finally, future trends were predicted using the Bayesian age-period-cohort model.</p><p><strong>Results: </strong>In 2021, there were 18,413,845 (95% uncertainty interval (<i>UI</i>): 15,765,620-21,547,032) prevalent cases and 102,961 (95% <i>UI</i>: 40,469-213,098) YLDs associated with STI-attributable infertility globally. The corresponding ASPR and ASYR per 100,000 population were 225.44 (95% <i>UI</i>: 193.19-262.80) and 1.26 (95% <i>UI</i>: 0.50-2.61), with EAPCs from 1990 to 2021 of 0 (95% confidence interval (<i>CI</i>): -0.05-0.06) and -0.01 (95% <i>CI</i>: -0.07-0.04), respectively. Chlamydia infection was identified as the primary contributor to this burden. Nationally, Guinea-Bissau had the highest burden, followed by Guinea and Mauritania. A significant inverse correlation was observed between the ASPR and socio-demographic index (SDI) levels. From 1990 to 2021, the disease burden exhibited an upward trend. Notably, the model predicted this increasing trend would continue across all age groups until 2050, with individuals aged 40 to 44 being the most affected.</p><p><strong>Conclusion: </strong>Infertility attributable to STIs remains a critical public health challenge, with a projected increasing trend through 2050. Global efforts to reduce the burden of infertility should focus on improving STI prevention, diagnosis, and treatment strategies, especially in regions with low and middle SDI levels.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 3","pages":"232-242"},"PeriodicalIF":1.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13387761/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148551600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Maternal-fetal medicine (Wolters Kluwer Health, Inc.)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1